Trials / Unknown
UnknownNCT01080638
Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Intracoronary bolus Abciximab single is non-inferior to intravenous and continuous 12- hours infusion in the size reduction of infarction on cardiac magnetic resonance in Non-ST elevation Myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | glycoprotein IIb/IIIa inhibitor (abciximab) | patients intracoronary bolus only group and intravenous bolus and 12-hours continuous infusion group bolus:0.25mg/kg body weight,continus 12hrs-0.125ug/kg per minute(maximum: 10ug/min) |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-03-04
- Last updated
- 2010-03-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01080638. Inclusion in this directory is not an endorsement.